NCT07011576
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07011576
Title A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC) (FRUITFUL)
Acronym FRUITFUL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors SCRI Development Innovations, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Rocky Mountain Cancer Center - Primary RECRUITING Denver Colorado 80218 United States Details
Maryland Oncology Hematology RECRUITING Columbia Maryland 21044 United States Details
Minnesota Oncology Hematology - Primary RECRUITING Maple Grove Minnesota 55369 United States Details
Oncology Associates of Oregon - Primary RECRUITING Eugene Oregon 97401 United States Details
Northwest Cancer Specialists - Compass RECRUITING Portland Oregon 97213 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Texas Oncology - Central/South Texas RECRUITING Austin Texas 78705 United States Details
Texas Oncology - Gulf Coast RECRUITING Beaumont Texas 77702 United States Details
Texas Oncology - Northeast Texas RECRUITING Tyler Texas 75702 United States Details
Virginia Oncology Associates RECRUITING Norfolk Virginia 23502 United States Details
Blue Ridge Cancer Care (Oncology & Hematology Associates of Southwest VA) RECRUITING Salem Virginia 24153 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field